Massachusetts Financial Services Co. MA Raises Stock Position in Definitive Healthcare Corp. (NASDAQ:DH)

Massachusetts Financial Services Co. MA increased its position in shares of Definitive Healthcare Corp. (NASDAQ:DHFree Report) by 28.3% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,426,420 shares of the company’s stock after buying an additional 976,279 shares during the period. Massachusetts Financial Services Co. MA’s holdings in Definitive Healthcare were worth $24,168,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in DH. Swiss National Bank increased its stake in Definitive Healthcare by 3.6% during the 4th quarter. Swiss National Bank now owns 100,400 shares of the company’s stock worth $998,000 after buying an additional 3,500 shares during the period. Norden Group LLC purchased a new stake in Definitive Healthcare during the 1st quarter worth $83,000. Conestoga Capital Advisors LLC grew its holdings in Definitive Healthcare by 1.3% during the 1st quarter. Conestoga Capital Advisors LLC now owns 5,595,627 shares of the company’s stock worth $45,157,000 after acquiring an additional 74,490 shares in the last quarter. Principal Financial Group Inc. acquired a new position in Definitive Healthcare during the 1st quarter worth $290,000. Finally, Oppenheimer Asset Management Inc. grew its holdings in Definitive Healthcare by 40.5% during the 1st quarter. Oppenheimer Asset Management Inc. now owns 49,393 shares of the company’s stock worth $399,000 after acquiring an additional 14,229 shares in the last quarter. Hedge funds and other institutional investors own 98.67% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on DH. Morgan Stanley decreased their price objective on shares of Definitive Healthcare from $9.00 to $5.00 and set an “equal weight” rating for the company in a report on Tuesday, August 6th. Needham & Company LLC reissued a “hold” rating on shares of Definitive Healthcare in a report on Tuesday, August 6th. BTIG Research began coverage on shares of Definitive Healthcare in a report on Tuesday. They set a “buy” rating and a $7.00 price objective for the company. Robert W. Baird decreased their price objective on shares of Definitive Healthcare from $6.00 to $5.00 and set a “neutral” rating for the company in a report on Wednesday, August 7th. Finally, Stifel Nicolaus decreased their price objective on shares of Definitive Healthcare from $9.50 to $7.50 and set a “buy” rating for the company in a report on Wednesday, July 31st. One analyst has rated the stock with a sell rating, seven have issued a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $5.81.

Read Our Latest Stock Analysis on Definitive Healthcare

Definitive Healthcare Trading Down 6.4 %

Shares of NASDAQ:DH opened at $4.50 on Friday. The company has a market cap of $530.71 million, a PE ratio of -2.57, a P/E/G ratio of 6.38 and a beta of 1.33. The company’s 50-day moving average price is $4.62 and its 200 day moving average price is $5.87. Definitive Healthcare Corp. has a fifty-two week low of $3.19 and a fifty-two week high of $10.62. The company has a quick ratio of 2.40, a current ratio of 2.40 and a debt-to-equity ratio of 0.27.

Definitive Healthcare (NASDAQ:DHGet Free Report) last issued its quarterly earnings data on Monday, August 5th. The company reported $0.09 earnings per share for the quarter, meeting the consensus estimate of $0.09. The firm had revenue of $63.70 million for the quarter, compared to the consensus estimate of $63.19 million. Definitive Healthcare had a negative net margin of 156.65% and a positive return on equity of 0.98%. Definitive Healthcare’s quarterly revenue was up 4.4% compared to the same quarter last year. During the same period last year, the firm posted $0.08 EPS. Sell-side analysts anticipate that Definitive Healthcare Corp. will post 0.07 earnings per share for the current year.

Definitive Healthcare Profile

(Free Report)

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.

Featured Stories

Want to see what other hedge funds are holding DH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Definitive Healthcare Corp. (NASDAQ:DHFree Report).

Institutional Ownership by Quarter for Definitive Healthcare (NASDAQ:DH)

Receive News & Ratings for Definitive Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Definitive Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.